Literature DB >> 16244785

The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida.

Lydia Voti1, Lisa C Richardson, Isildinha Reis, Lora E Fleming, Jill Mackinnon, Jan Willem W Coebergh.   

Abstract

OBJECTIVES: Assess the effect of race/ethnicity and insurance coverage on the receipt of standard treatment for local breast cancer.
METHODS: Local breast cancers diagnosed between July 1997 and December 2000 and reported to Florida's registry were linked to the Agency of Healthcare Administration inpatient and outpatient databases, resulting in 23,817 female local breast cancers with informative treatment. Standard treatment was defined as mastectomy or breast-conserving surgery followed by radiation therapy and it was modeled as a function of health insurance and race/ethnicity accounting for age at diagnosis, marital status and facility type.
RESULTS: Approximately 88% of the local breast cancers received standard treatment. The likelihood of standard treatment decreased by 3% per year of increase in the age at diagnosis. Compared to white non-Hispanic, black non-Hispanic women were 19% less likely to receive standard treatment (OR=0.81, 95%CI=0.68, 0.97) and Hispanics were 23% less likely (OR=0.77, 95%CI=0.66, 0.89). Local breast cancers diagnosed in non-teaching facilities were 21% more likely to receive standard treatment compared to those diagnosed in teaching facilities (OR=1.21; 95%CI=1.05, 1.38)). Compared to single, married women were 51% more likely to get standard treatment (OR=1.51, 95%CI=1.31, 1.66), followed by separated or divorced women that were 37% more likely (OR=1.37, 95%CI =1.13, 1.66). Compared to the privately insured, Medicare beneficiaries were 36% more likely to receive standard treatment (OR=1.36, 95%CI=1.22, 1.51) whereas the uninsured were 24% less likely (OR=0.76, 95%CI=0.59, 0.96); Medicaid insured women were 29% less likely to receive standard treatment compared to the uninsured (OR=0.71, 95%CI=0.53, 0.96).
CONCLUSION: Future efforts should target the elderly, Hispanic and black women, the uninsured, and those on Medicaid in order to reduce treatment disparities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244785     DOI: 10.1007/s10549-005-9050-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  24 in total

1.  Regarding "Associations between socioeconomic status and cancer survival".

Authors:  Kevin M Gorey
Journal:  Ann Epidemiol       Date:  2006-08-01       Impact factor: 3.797

2.  Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975-2001.

Authors:  Kevin M Gorey; Isaac N Luginaah; Kendra L Schwartz; Karen Y Fung; Madhan Balagurusamy; Emma Bartfay; Frances C Wright; Uzoamaka Anucha; Renee R Parsons
Journal:  Breast Cancer Res Treat       Date:  2008-03-11       Impact factor: 4.872

3.  Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?

Authors:  Cary P Gross; Benjamin D Smith; Elizabeth Wolf; Martin Andersen
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

4.  American Society of Clinical Oncology policy statement on medicaid reform.

Authors:  Blase N Polite; Jennifer J Griggs; Beverly Moy; Christopher Lathan; Nefertiti C duPont; Gina Villani; Sandra L Wong; Michael T Halpern
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

5.  Intraoperative radiotherapy (IORT) versus whole-breast external beam radiotherapy (EBRT) in early stage breast cancer: results from SEER database.

Authors:  Juan Lei; Yi Wang; Zhuofei Bi; Shengneng Xue; Bing Ou; Kan Liu
Journal:  Jpn J Radiol       Date:  2019-11-05       Impact factor: 2.374

6.  Breast Cancer Treatment and Survival Among Department of Defense Beneficiaries: An Analysis by Benefit Type and Care Source.

Authors:  Janna Manjelievskaia; Derek Brown; Stephanie Shao; Keith Hofmann; Craig D Shriver; Kangmin Zhu
Journal:  Mil Med       Date:  2018-03-01       Impact factor: 1.437

7.  Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors.

Authors:  Stephanie Brooke Wheeler; Racquel Elizabeth Kohler; Katherine Elizabeth Reeder-Hayes; Ravi K Goyal; Kristen Hassmiller Lich; Alexis Moore; Timothy W Smith; Cathy L Melvin; Hyman Bernard Muss
Journal:  J Cancer Surviv       Date:  2014-05-28       Impact factor: 4.442

8.  Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.

Authors:  Gery P Guy; Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Kevin C Ward
Journal:  Health Serv Res       Date:  2014-12-10       Impact factor: 3.402

9.  Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study.

Authors:  Grace L Smith; Ya-Chen T Shih; Ying Xu; Sharon H Giordano; Benjamin D Smith; George H Perkins; Welela Tereffe; Wendy A Woodward; Thomas A Buchholz
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

10.  Incremental value of using Medicaid claim files to study comorbid conditions and treatments in dually eligible beneficiaries.

Authors:  Cathy J Bradley; Bassam Dahman; Paul M Bataki; Siran Koroukian
Journal:  Med Care       Date:  2010-01       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.